Target Information
| Target General Infomation | |||||
|---|---|---|---|---|---|
| Target ID |
T47215
|
||||
| Former ID |
TTDR00566
|
||||
| Target Name |
CCK receptor
|
||||
| Target Type |
Discontinued
|
||||
| Disease | Obesity [ICD9: 278; ICD10: E66] | ||||
| Drugs and Mode of Action | |||||
| Drug(s) | A-68552 | Drug Info | Terminated | Obesity | [1] |
| Modulator | A-68552 | Drug Info | [2] | ||
| Antagonist | Loxiglumide | Drug Info | [3] | ||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001851) | ||||
| REF 2 | CN patent application no. 102481276, Chemosensory receptor ligand-based therapies. | ||||
| REF 3 | Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines. FEBS Lett. 1996 Apr 1;383(3):241-4. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.